Cas:21066-20-6 methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) manufacturer & supplier

We serve Chemical Name:methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) CAS:21066-20-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate)

Chemical Name:methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate)
CAS.NO:21066-20-6
Synonyms:(3ALPHA,5BETA,12ALPHA)-3,12-BIS(ACETYLOXY)-7-OXOCHOLAN-24-OIC ACID METHYL ESTER;3Alpha,12Alpha-diacetoxy-7-oxo-5Beta-cholan-24-oic acid methyl ester
Molecular Formula:C29H44O7
Molecular Weight:504.65500
HS Code:

Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:95.97000
Exact Mass:504.30900
LogP:4.88690

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like (3ALPHA,5BETA,12ALPHA)-3,12-BIS(ACETYLOXY)-7-OXOCHOLAN-24-OIC ACID METHYL ESTER chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3Alpha,12Alpha-diacetoxy-7-oxo-5Beta-cholan-24-oic acid methyl ester physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3Alpha,12Alpha-diacetoxy-7-oxo-5Beta-cholan-24-oic acid methyl ester Use and application,(3ALPHA,5BETA,12ALPHA)-3,12-BIS(ACETYLOXY)-7-OXOCHOLAN-24-OIC ACID METHYL ESTER technical grade,usp/ep/jp grade.


Related News: These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) manufacturer In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks. methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) supplier These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) vendor These mathematical dosing algorithms were developed in the Damiano Lab at Boston University and refined based on results from home-use clinical trials in adults and children with T1D. Beta Bionics is a Certified B Corporation? whose founders �� in addition to Ed Damiano �� include other parents of children with type 1 diabetes and people with type 1 diabetes. Beta Bionics is committed to acting in the best interests of the diabetes community and to profoundly disrupting the diabetes medical device industry by bringing the iLet to market as expeditiously and responsibly as possible. methyl 7-dehydrocholate diacetate (methyl 3α,12α-diacetoxy-7-oxo-5β-cholan-24-oate) factory In its message to the public, the FDA said that a person should consider being retested if they used Innova’s diagnostic within the past two weeks.